These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19903454)

  • 1. Letter to the editor on "Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals".
    Hamilton BA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1154. PubMed ID: 19903454
    [No Abstract]   [Full Text] [Related]  

  • 2. Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.
    Larsen K; Hedegaard C; Bertelsen MF; Bendixen C
    Biochem Biophys Res Commun; 2009 Sep; 387(3):602-5. PubMed ID: 19619507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease.
    Ki CS; Stavrou EF; Davanos N; Lee WY; Chung EJ; Kim JY; Athanassiadou A
    Clin Genet; 2007 May; 71(5):471-3. PubMed ID: 17489854
    [No Abstract]   [Full Text] [Related]  

  • 4. alpha-Synuclein gene duplications in sporadic Parkinson disease.
    Theuns J; Van Broeckhoven C
    Neurology; 2008 Jan; 70(1):7-9. PubMed ID: 18166703
    [No Abstract]   [Full Text] [Related]  

  • 5. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
    Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain-resistant fragment(s) of alpha-synuclein regulates the synuclein-cleaving activity of 20S proteasome.
    Kim HJ; Lee D; Lee CH; Chung KC; Kim J; Paik SR
    Arch Biochem Biophys; 2006 Nov; 455(1):40-7. PubMed ID: 17005155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
    Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
    J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
    Kao SY
    Biochem Biophys Res Commun; 2009 Jul; 385(3):434-8. PubMed ID: 19470380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.
    Berg D; Niwar M; Maass S; Zimprich A; Möller JC; Wuellner U; Schmitz-Hübsch T; Klein C; Tan EK; Schöls L; Marsh L; Dawson TM; Janetzky B; Müller T; Woitalla D; Kostic V; Pramstaller PP; Oertel WH; Bauer P; Krueger R; Gasser T; Riess O
    Mov Disord; 2005 Sep; 20(9):1191-4. PubMed ID: 15895422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation.
    Battisti C; Formichi P; Radi E; Federico A
    J Neurol Sci; 2008 Apr; 267(1-2):120-4. PubMed ID: 18061619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Troiano AR; Cazeneuve C; Le Ber I; Bonnet AM; Lesage S; Brice A
    Neurology; 2008 Oct; 71(16):1295; author reply 1295. PubMed ID: 18852449
    [No Abstract]   [Full Text] [Related]  

  • 14. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Krüger R; Kuhn W; Müller T; Woitalla D; Graeber M; Kösel S; Przuntek H; Epplen JT; Schöls L; Riess O
    Nat Genet; 1998 Feb; 18(2):106-8. PubMed ID: 9462735
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Brueggemann N; Odin P; Gruenewald A; Tadic V; Hagenah J; Seidel G; Lohmann K; Klein C; Djarmati A
    Neurology; 2008 Oct; 71(16):1294; author reply 1294. PubMed ID: 18852448
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
    Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snaring the function of alpha-synuclein.
    Bonini NM; Giasson BI
    Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.